We also assessed whether the expression of EIF4EBP1 is determined by NB stages or risk groups, and found that EIF4EBP1 levels are increased according to NB tumor aggressiveness in two cohorts (Fig. 1f, g). This evidence concerns the gene EIF4EBP1 and neuroblastoma.